2nd enhanced Solubility & Bioavailability:

Register Now

Download Presenations

Assesing HT solubility platforms in discovery and development Dr. Jochem Alsenz, F. Hoffmann-La Roche Ltd.

Assesing One Technology - Multiple Applications: Melt Processing for Tailored Product Characteristics Dr. Jörg Breitenbach, SOLIQS

A good forum for discovering the current status of dissolution and solubility challenges in drug delivery

R. J. Taylor, Director, UCB

In order to maximize the effectiveness of pharmaceuticals, two main challenges have to be mastered: Ensuring the solubility of a lead and increasing its bioavailability. Both issues have to be faced in different phases of drug development, starting with the first screening and lead identification, right up until the formulation process and clinical development. Innovative technologies and methods do not only help to develop this process of drug research more efficiently but also to meet time to market requirements. Focusing on the question of how to increase the performance of poorly soluble compounds, formulation scientists and drug development experts present ground-breaking solutions.

Successfully master the latest challenges regarding solubility:

Efficiently improve oral absorption of sparingly soluble drugs by implementing self-emulsifying drug delivery systems
Explore advantages of using nanotechnology for drug delivery to enhance API bioavailability
Find out how to fasten time to market by identifying in vitro-in vivo correlations
Get to know the latest methods on toxicity testing to maximise the exposure of water-insoluble drugs
Increase the efficiency of your R&D process by using formulation strategies in early phase development

Hear case studies from leading international companies:

Novartis Pharma AG,Switzerland
Johnson & JohnsonServices Inc., UK
Bristol-Myers Squibb Company, USA
Capsugel, Division of Pfizer, Belgium
Université d’Auvergne, France
University of Athens, Greece
Bial S.A., Portugal
Gattefosse SAS, France
Eurand S.p.A., Italy
Pierre Fabre Laboratories, France
TNO Quality of Life, The Netherlands
AustarPharma LLC, USA
Solvay Pharmaceuticals B.V., Belgium
Æterna Zentaris, Germany
University of Athens, Greece

If you are not yet ready to register, feel free to request a reminder nearer the time.

Conference Partners

Medienpartner

[ Register Now] · [ Next: Conference Day One: Tuesday, 10th February 2009 ]